Delivery Order SPE2DB22D3501-SPE2DB25FUC17
Award Date
1/10/25
Potential Completion Date
1/13/25
Potential Value
$6.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, as the prime contractor. The contract is for the delivery of pharmaceutical products, specifically the drug Emgality 120 mg/mL pen, to support military treatment programs and facilities. The award has a ceiling value of $1,002.72 and a period of performance through March 25, 2024. This delivery order is issued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,179.64 firm-fixed-price contract is for the supply of Emgality 120 mg/ml pens, a prescription medication. The contract has a period of performance through September 12, 2024. This order is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Emgality 120 mg/ml pens. The contract has a ceiling value of $1,729 and was awarded by the Defense Logistics Agency (DLA), a defense agency, on February 3, 2025, with a final completion date of February 4, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,969.14 firm-fixed-price delivery order covers the supply of Emgality 120 mg/ml pen to DLA. The contract has an ultimate completion date of November 29, 2023 and was awarded on November 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emgality 120 mg/ml pens, a medication used for the treatment of migraines. The contract has a ceiling value of $1,124.81 and runs through February 16, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Emgality 120 mg/ml injectable medication. The contract, valued at $1,002.72, has a performance period through August 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This federal contract award, with ID SPE2DB20D1050|SPE2DB25FH48Q, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,112.94, is a Firm Fixed Price Delivery Order for the product Emgality 120 mg/ml PenML. The ultimate completion date is February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Emgality 120 mg/ml pens. The $1,897.69 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of February 6, 2025 and was awarded on February 5, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) the company holds with the DLA, valued at $999,999,999 and running...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the delivery of Emgality 120 mg/ml pens. The contract has a ceiling value of $2,593.50 and is a firm fixed-price delivery order with a completion date of January 15, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,729.00, is for the provision of the drug Emgality 120 mg/ml. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...